Research

Breakthrough in MS treatment

Published: 9Jan2017

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary...

The importance of research

Dr. Céline Gélinas (second from left) and her research team. At the Ingram School of Nursing, dedicated clinical and university-based faculty members are accomplished leaders in the fields of...